Investment Thesis
Novalis Biotech invests in early-stage life sciences startups focused on enabling technologies. The firm emphasizes capital-light platform solutions, close customer interaction, and strategic support to accelerate company growth and value creation.
Stage Focus
Early-stage startups (pre-seed to Series A)
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Enabling technologies in life sciences, including innovative research and manufacturing tools, bioinformatics, genomics, diagnostics, and digital health
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
€2,000,000 - €2,000,000
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
